What is MediPharm Labs Corp. (MEDIF) stock price today?

MediPharm Labs Corp. (MEDIF) is currently trading at $0.06, up 1.66% today.

What is MEDIF P/E ratio?

MediPharm Labs Corp.'s P/E ratio is -3.62. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is MEDIF return on equity (ROE)?

MediPharm Labs Corp.'s return on equity (ROE) is -23.55%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is MediPharm Labs Corp.'s market cap?

MediPharm Labs Corp. has a market capitalization of $23.37M.

OTC · Drug Manufacturers - Specialty & Generic

MediPharm Labs Corp. (MEDIF) Stock

$0.06 +1.66% OTC: MEDIF Healthcare

MediPharm Labs Corp. operates as a pharmaceutical firm specializing in the manufacturing and distribution of pharmaceutical-grade cannabis oils, concentrates, and advanced derivative products.

Valuation

Metric	Value
Price	$0.06
Market Cap	$23.37M
P/E Ratio	-3.62
P/B Ratio	0.91
P/S Ratio	0.74
EPS (TTM)	$-0.02
52-Week High	$0.08
52-Week Low	$0.04
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-23.55%
ROA	-20.05%
ROCE	-25.12%
Gross Margin	30.63%
Operating Margin	-20.37%
Net Margin	-20.21%
Debt/Equity	0.00
Current Ratio	3.02

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$22.0M	$22.0M	$33.0M	$42.0M	$45.0M
Operating Profit	$-49.0M	$-30.0M	$-18.0M	$-11.0M	$-9.0M
Net Profit	$-55.0M	$-30.0M	$-13.0M	$-11.0M	$-8.0M
EPS	$-0.22	$-0.11	$-0.04	$-0.03	$-0.02
Op Margin	-225.3%	-133.5%	-55.2%	-25.8%	-19.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$92.0M	$65.0M	$64.0M	$54.0M	$46.0M
Total Liabilities	$9.0M	$9.0M	$11.0M	$11.0M	$10.0M
Cash	$34.0M	$24.0M	$18.0M	$12.0M	$11.0M
Borrowings	$0	$1.0M	$2.0M	$0	$0

Latest News

MediPharm Reports Positive Phase 2 LiBBY Trial Results in Patients With Advanced Dementia MT Newswires · Jul 14, 2026 MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia GlobeNewswire · Jul 14, 2026 MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders GlobeNewswire · Jun 17, 2026 MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting GlobeNewswire · May 28, 2026 MediPharm Labs Corp (MEDIF) Q1 2026 Earnings Call Highlights: Strategic International Expansion ... GuruFocus.com · May 13, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-13.0M	$-16.0M	$-12.0M	$-5.0M	$-5.0M
Investing Cash Flow	$0	$4.0M	$8.0M	$0	$5.0M
Financing Cash Flow	$0	$0	$1.0M	$0	$0
Net Cash Flow	$14.0M	$-10.0M	$-6.0M	$-6.0M	$0
Free Cash Flow	$-14.0M	$-17.0M	$-12.0M	$-5.0M	$-5.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-2.37
EV / EBITDA	-3.12
FCF Yield	-10.45%
Quick Ratio	2.03
Interest Coverage	-142.18
Return 1Y	5.88%
Return 3Y	20.00%
Return 5Y	-83.93%

Ownership

Insiders Held11.64%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Gamma Investing LLC	200	2026-06-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AVCNFAvicanna Inc.	$0.10	+4.32%	-4.25	$12.15M	0.00%
CAAOFINDVR Brands Inc.	$0.00	—	0.00	$3025	0.00%
CHOOFChoom Holdings Inc.	$0.00	—	0.00	$4670	0.00%
CWBHFCharlotte's Web Holdings, Inc.	$0.25	+4.12%	-1.08	$39.86M	0.00%
EVRRFMolecule Holdings Inc.	$0.00	—	-0.11	$626130	0.00%

About MediPharm Labs Corp.

MediPharm Labs Corp. operates as a pharmaceutical firm specializing in the manufacturing and distribution of pharmaceutical-grade cannabis oils, concentrates, and advanced derivative products. The company's market presence spans Canada, Australia, Germany, and other international territories. Its comprehensive services encompass the formulation, processing, packaging, and distribution of sophisticated cannabinoid-based offerings. Additionally, MediPharm Labs provides GMP-compliant sourcing, packaging, and distribution services for cannabis flower. The organization was established in 2015 and is headquartered in Barrie, Canada.

MediPharm Labs Corp. is headquartered in CA.

MediPharm Labs Corp. (MEDIF) stock trades at $0.06 with a market capitalization of $23.37M. The stock is valued at a price-to-earnings (P/E) ratio of -3.62, price-to-book of 0.91, price-to-sales of 0.74. Over the past 52 weeks the stock has ranged between $0.04 and $0.08, and currently trades 25.0% below its 52-week high.

On profitability, MediPharm Labs Corp. generates a return on equity (ROE) of -23.55%, return on capital employed of -25.12%, an operating margin of -20.37%, a net profit margin of -20.21%.

Official website: www.medipharmlabs.com